Ftse Mib
36.771,57
0,52%
DAX
21.712,64
0,74%
S&P 500
6.061,48
0,39%
NASDAQ
19.692,33
0,19%
Bitcoin
98.698,88
2,15%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Amgen Inc (AMGN) Amgen Inc (AMGN) Notizie

Amgen Inc

AMGN
308,99
1,18 (0,38%)
Pre Mercato
Ultimo aggiornamento: 12:07:36
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202518:53EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:05EDGAR2Form 8-K - Current report
04/2/202522:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL..
01/2/202500:30PRNUSAMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR..
29/1/202522:01PRNUSEUROPEAN COMMISSION APPROVES BLINCYTO® IN PHILADELPHIA..
17/1/202515:01PRNUSFDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH..
08/1/202522:01PRNUSAMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE..
10/12/202422:30PRNUSAMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND
07/12/202416:00PRNUSBLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY..
07/12/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202415:00PRNUSAMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH..
04/12/202401:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:00PRNUSAMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE
29/11/202422:30PRNUSAMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx..
26/11/202413:05PRNUSAMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE..
26/11/202413:00PRNUSAMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS..
20/11/202422:00PRNUSAMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
14/11/202422:00PRNUSAMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT..
13/11/202421:27PRNUSMOORE LAW ENCOURAGES AMGEN INC. INVESTORS TO CONTACT LAW..
13/11/202411:00PRNUSAMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
08/11/202422:00PRNUSAMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE..
08/11/202408:00PRNUSTEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR..
07/11/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202401:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202401:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202412:13IHMARKETNEWSMicrosoft and Meta Decline Up to 4%; Roku Falls 14% Amid..
30/10/202421:06EDGAR2Form 8-K - Current report
30/10/202421:01PRNUSAMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
25/10/202422:00PRNUSAMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND
24/10/202422:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL..
15/10/202414:00PRNUSAMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA®..
01/10/202415:00PRNUSLA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID,..
25/9/202422:45IHMARKETNEWSDow, S&P Come Off Record Highs, Close On Weak Note
24/9/202422:00PRNUSTEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE..
23/9/202422:00PRNUSAMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN..
13/9/202415:00PRNUSAMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL..
09/9/202415:00PRNUSAMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™..
30/8/202422:00PRNUSAMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE..
29/8/202422:00PRNUSAMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL..
23/8/202422:20EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
20/8/202415:00PRNUSOTEZLA® (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE..
13/8/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202411:42IHMARKETNEWSNovo Nordisk Adjusts Outlook, Airbnb Drops 16% on Declining..
06/8/202422:05EDGAR2Form 8-K - Current report
06/8/202422:01PRNUSAMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
06/8/202411:49IHMARKETNEWSUS Index Futures Rise After Market Sell-off, Oil Prices Trim..
Apertura: Min: Max:
Chiusura: 307,81

La tua Cronologia

NASDAQ
AMGN
Amgen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci